|
|
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study
Marie Auvray Kuentz
,
Vincent Hautefeuille
,
Louis de Mestier
,
Clelia Coutzac
,
Thierry Lecomte
et al.
Journal articles
hal-03969427v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort.
Aline Derosiere
,
Vincent Nicolai
,
David Malka
,
Astrid Pozet
,
Julien Lazartigues
et al.
Journal articles
hal-03606012v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FLASH-RAS : Etat des lieux des tests RAS chez des patients atteint d’un cancer colorectal métastatique en 2014
Jean-Louis Merlin
,
Astrid Lièvre
,
Pierre Laurent-Puig
,
Michel Ducreux
,
Pascal Artru
et al.
7ème colloque de pharmaco-épidémiologie, Jun 2015, Paris, France
Conference papers
hal-01241770v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
Debora Basile
,
Chloé Broudin
,
Jean François J.F. Emile
,
Antoine Falcoz
,
Franck Pagès
et al.
Journal articles
hal-03703634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014
Astrid Lièvre
,
Jean-Louis Merlin
,
Jean-Christophe Sabourin
,
Pascal Artru
,
Sabine Tong
et al.
Journal articles
hal-01778377v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
Sonia Zaibet
,
Vincent Hautefeuille
,
Edouard Auclin
,
Astrid Lièvre
,
David Tougeron
et al.
Journal articles
hal-03555280v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)
Antoine Brouquet
,
Jean-Baptiste Bachet
,
Florence Huguet
,
Mehdi Karoui
,
Pascal Artru
et al.
Journal articles
hal-03597474v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Review of the current status of KRAS mutation testing in France in 2011: The Flash-KRAS study
Pascal Artru
,
Michel Ducreux
,
Astrid Lièvre
,
Michel Guiu
,
Jean-Louis Merlin
et al.
Annual Meeting of the American Society of Clinical Oncology, ASCO'2012, Jun 2012, Chicago, Illinois, United States. pp.CDROM
Conference papers
hal-00747407v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic factors of colorectal cancer patients with brain metastases
Pauline Roussille
,
Marie Auvray
,
Damien Vansteene
,
Thierry Lecomte
,
Eugénie Rigault
et al.
Journal articles
hal-03237457v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study
Anne-Laure Pointet
,
David Tougeron
,
Simon Pernot
,
Astrid Pozet
,
Dominique Béchade
et al.
Journal articles
hal-03491049v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Nicolas Williet
,
Angélique Saint
,
Anne-Laure Pointet
,
David Tougeron
,
Simon Pernot
et al.
Journal articles
hal-02532994v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study
Claire Gallois
,
Pascal Artru
,
Astrid Lièvre
,
Edouard Auclin
,
Thierry Lecomte
et al.
Journal articles
hal-03487266v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
Leo Mas
,
Jean-Baptiste Bachet
,
Valérie Taly
,
Olivier Bouché
,
Julien Taïeb
et al.
Journal articles
inserm-02299478v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
Florence Huguet
,
Thierry André
,
Pascal Hammel
,
Pascal Artru
,
Jacques Balosso
et al.
Journal articles
inserm-00383864v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Etat des lieux des tests RAS chez les patients atteints de cancer colorectal métastatique en 2014
Jean-Christophe Sabourin
,
Jean-Louis Merlin
,
Astrid Lièvre
,
Michel Ducreux
,
Pascal Artru
et al.
Carrefour Pathologie, Nov 2015, Paris, France
Conference papers
hal-01241777v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy
,
Pascal Hammel
,
Mohamed Hebbar
,
Meher Ben Abdelghani
,
Alice Wei
et al.
Journal articles
hal-02281628v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Etat des lieux du test KRAS chez des patients atteints d'un cancer colorectal métastatique, en France en 2011 - Etude Flash-KRAS
Astrid Lièvre
,
Pascal Artru
,
Michel Guiu
,
Pierre Laurent-Puig
,
Jean-Louis Merlin
et al.
Journées Francophones d'Hépatogastro-entérologie et d'Oncologie Digestive, JFHOD 2012, Mar 2012, Paris, France. pp.CDROM
Conference papers
hal-00747738v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Étude Flash KRAS : étude transversale observationnelle, rétrospective, faisant un état des lieux du test KRAS en 2011 chez des patients ayant commencé récemment un traitement de première ligne pour un cancer colorectal métastatique (CCRm) : méthodologie de l'étude et premiers résultats
Jean-Christophe Sabourin
,
Pascal Artru
,
Michel Ducreux
,
Michel Guiu
,
Astrid Lièvre
et al.
Conference papers
hal-00747875v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Review of the current status of RAS mutation testing in patients with metastatic colorectal cancer (mCRC): Flash-RAS study
Jean-Christophe Sabourin
,
Astrid Lièvre
,
Jean-Louis Merlin
,
Michel Ducreux
,
Pascal Artru
et al.
18th Annual European Congress of the International Society for Pharmacoeconomics and Outcome Research, ISPOR, Nov 2015, Milan, Italy
Conference poster
hal-01241776v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011
Astrid Lièvre
,
Pascal Artru
,
Michel Guiu
,
Pierre Laurent-Puig
,
Jean-Louis Merlin
et al.
Journal articles
hal-00974915v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|